- Case report
- Open Access
- Open Peer Review
Subaortic and midventricular obstructive hypertrophic cardiomyopathy with extreme segmental hypertrophy
© Efthimiadis et al; licensee BioMed Central Ltd. 2007
- Received: 28 February 2007
- Accepted: 12 March 2007
- Published: 12 March 2007
Subaortic and midventricular hypertrophic cardiomyopathy in a patient with extreme segmental hypertrophy exceeding the usual maximum wall thickness reported in the literature is a rare phenomenon.
A 19-year-old man with recently diagnosed hypertrophic cardiomyopathy (HCM) was referred for sudden death risk assessment. The patient had mild exertional dyspnea (New York Heart Association functional class II), but without syncope or chest pain. There was no family history of HCM or sudden death. A two dimensional echocardiogram revealed an asymmetric type of LV hypertrophy; anterior ventricular septum = 49 mm; posterior ventricular septum = 20 mm; anterolateral free wall = 12 mm; and posterior free wall = 6 mm. The patient had 2 types of obstruction; a LV outflow obstruction due to systolic anterior motion of both mitral leaflets (Doppler-estimated 38 mm Hg gradient at rest); and a midventricular obstruction (Doppler-estimated 43 mm Hg gradient), but without apical aneurysm or dyskinesia. The patient had a normal blood pressure response on exercise test and no episodes of non-sustained ventricular tachycardia in 24-h ECG recording. Cardiac MRI showed a gross late enhancement at the hypertrophied septum. Based on the extreme degree of LV hypertrophy and the myocardial hyperenhancement, an implantation of a cardioverter-defibrillator was recommended prophylactically for primary prevention of sudden death.
Midventricular HCM is an infrequent phenotype, but may be associated with an apical aneurysm and progression to systolic dysfunction (end-stage HCM).
- Left Ventricular Hypertrophy
- Hypertrophic Cardiomyopathy
- Mitral Leaflet
- Systolic Anterior Motion
- Hypertrophied Septum
Midventricular hypertrophic cardiomyopathy (HCM) is an infrequent phenotype, but may be associated with an apical aneurysm and progression to systolic dysfunction (end-stage HCM) .
This case is a rare example of a patient with subaortic and midventricular hypertrophic cardiomyopathy with extreme segmental hypertrophy exceeding the usual maximum wall thickness reported in the literature, although Maron et al have published a case of a patient with an even greater hypertrophy (60 mm) .
- Efthimiadis GK, Giannakoulas G, Parharidou DG, Karvounis HI, Mochlas ST, Styliadis IH, Gavrielides S, Gemitzis KD, Giannoglou GD, Parharidis GE, Louridas GE: Prevalence of Systolic Impairment in an Unselected Regional Population With Hypertrophic Cardiomyopathy. Am J Cardiol 2006, 98: 1269-1272. 10.1016/j.amjcard.2006.05.063View ArticlePubMedGoogle Scholar
- Maron BJ, Gross BW, Stark SI: Extreme left ventricular hypertrophy. Circulation 1995, 92: 2748.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.